TrialScientific reports2023

Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)-a randomized trial.

Zhiming Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.